Selective serotonin 5-HT1A receptor biased agonists elicitdistinct brain activation patterns: a pharmacoMRI study

• Published in: Scientific reports Vol. 6; no. 1; p. 26633
• Main Authors: Becker, G., Bolbos, R., Costes, N., Redouté, J., Newman-Tancredi, A., Zimmer, L.
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 23-05-2016; Nature Publishing Group
• Subjects: 59/36; 631/378/340; 64; 692/4017; 8-Hydroxy-2-(di-n-propylamino)tetralin; Brain; Brain mapping; Drug delivery; Drug development; Functional magnetic resonance imaging; Humanities and Social Sciences; Intracellular signalling; multidisciplinary; Neuroimaging; Rodents; Science; Serotonin S1 receptors
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/srep26633

Serotonin 1A (5-HT
1A
) receptors are involved in several physiological and pathological processes and constitute therefore an important therapeutic target. The recent pharmacological concept of biased agonism asserts that highly selective agonists can preferentially direct receptor signaling to specific intracellular responses, opening the possibility of drugs targeting a receptor subtype in specific brain regions. The present study brings additional support to this concept thanks to functional magnetic resonance imaging (7 Tesla-fMRI) in anaesthetized rats. Three 5-HT
1A
receptor agonists (8-OH-DPAT, F13714 and F15599) and one 5-HT
1A
receptor antagonist (MPPF) were compared in terms of influence on the brain blood oxygen level-dependent (BOLD) signal. Our study revealed for the first time contrasting BOLD signal patterns of biased agonists in comparison to a classical agonist and a silent antagonist. By providing functional information on the influence of pharmacological activation of 5-HT
1A
receptors in specific brain regions, this neuroimaging approach, translatable to the clinic, promises to be useful in exploring the new concept of biased agonism in neuropsychopharmacology.